Childhood obesity and hormonal abnormalities associated with cancer risk

European Journal of Cancer Prevention

Volumn 13, Issue 3, 2004, Pages 193-197

  Gascon F ^a   Valle, M ^a   Martos, R ^b   Zafra, M ^a   Morales, R ^a   Castano M A ^a  

^a Hospital Valle de los Pedroches   (Spain)

^b Basic Health Zone of Pozoblanco   (Spain)

Author keywords

Cancer; Children; IGF I; Obesity; Oestradiol; Sex hormone binding globulin

Indexed keywords

ESTRADIOL; INSULIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; CANCER RISK; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE DISEASE; FEMALE; HUMAN; HYPERINSULINEMIA; MALE; MULTIVARIATE ANALYSIS; OBESITY; PREDICTION; PRIORITY JOURNAL; PUBERTY; RISK FACTOR;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD WELFARE; FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOPLASMS; OBESITY; RISK ASSESSMENT; SEX HORMONE-BINDING GLOBULIN;

EID: 2942683357     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000130021.16182.c3     Document Type: Article

References (44)

1. Barrett JC (2000). Molecular and environmental causes of cancer. Drug Metab Rev 32: 139-142.
2. Bianchini F, Kaaks R, Vainio H (2002). Weight control and physical activity in cancer prevention. Obesity Rev 3: 5-8.
3. Buijs MM, Romijn JA, Burggraaf J, et al. (2002). Growth hormone blunts protein oxidation and promotes protein turnover to a similar extent in abdominally obese and normal-weight women. J Clin Endocrinol Metab 87: 5668-5674.
4. Bustin SA, Jenkins PJ (2001). The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 7: 447-454.
5. Chinn S, Rona RJ (2001). Prevalence and trends in overweight and obesity in three cross sectional studies of British children, 1974-1994. BMJ 322: 24-26.
6. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M (1995). Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (HepG2) cells. J Clin Endocrinol Metab 80: 1283-1289.
7. Dietz WH (2001). The obesity epidemic in young children. BMJ 322: 313-314.
8. Douyon L, Schteingart DE (2002). Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am 31: 173-189.
9. Friedenreich CM, Orenstein MR (2002). Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132: 3456S-3464S.
10. Gascón F, Valle M, Martos R, et al. (2000). Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. Eur J Endocrinol 143: 85-89.
11. Giovannucci E (2001). Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: 3109S-3120S.
12. Goodwin PJ, Ennis M, Pritchard KI, et al. (2002). Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat 74: 65-76.
13. Goran MI (2001). Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. Am J Clin Nutr 73: 158-171.
14. Grundy SM (2000). Metabolic complications of obesity. Endocrine 13: 155-165.
15. Henderson BE, Feidelson HS (2000). Hormonal carcinogenesis. Carcinogenesis 21: 427-433.
16. Holly JMP, Gunnell DJ, Smith GD (1999). Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 162: 321-330.
17. James PhT, Leach R, Kalamara E, Shayeghi M (2001). The worldwide obesity epidemic. Obesity Res 9: 228S-233S.
18. Janssen JA, Burger H, Stolk RP, et al. (1998). Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138: 617-618.
19. Kaaks R, Lukanova A (2002). Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Ann N Y Acad Sci 963: 268-281.
20. Kaaks R, Toniolo P, Akhmedkhanov A, et al. (2000). Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-Binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
21. Key TJ, Allen NE, Spencer EA, Travis RC (2002). The effect of diet on risk of cancer. Lancet 360: 861-868.
22. l'Allemand D, Schmidt S, Rousson V, Brabant G, Gasser T, Gruters A (2002). Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche. Eur J Endocrinol 146: 537-543.
23. Liehr JG (2000). Is estradiol a genotoxic mutagenic carcinogen? Endocrinol Rev 21: 40-54.
24. Loukovaara M, Carson M, Adlercreutz H (1995). Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocrinol Metab 80: 160-164.
25. Maccario M, Tassone F, Grottoli S, et al. (2002). Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann D'Endocrinol (Paris) 63(2 Pt 1): 140-144.
26. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ (2001). Do different dimensions of the metabolic syndrome change together over time? evidence supporting obesity as the central features. Diabetes Care 24: 1758-1763.
27. McCarty MF (1997). Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity. Med Hypoth 48: 297-308.
28. Mokdad AH, Serdula MK, Dietz WH, et al. (2000). The continuing epidemic of obesity in the United States. JAMA 284: 1650-1651.
29. Moyad MA (2002). Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology 59: 41S-50S.
30. Nagata Ch, Shimizu H, Takami R, et al. (2000). Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors. Jpn J Cancer Res 91: 948-953.
31. Ohrn K, Al-Kahlili B, Huggare J, Forsberg CM, Marcus C, Dahllof G (2002). Craniofacial morphology in obese adolescents. Acta Odontol Scand 60: 193-197.
32. Okasha M, McCarron P, McEwen J, Smith GD (2002). Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Commun Health 56: 780-784.
33. Phillip M, Moran O, Lazar L (2002). Growth without growth hormone. J Pediatr Endocrinol Metab 15: 1267S-1272S.
34. Radetti G, Bozzola M, Pasquino B, et al. (1998). Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children. Metabolism 47: 1490-1493.
35. Reed AH, Henry RJ, Mason WB (1971). Influence of statistical method used on the resulting estimate of normal range. Clin Chem 17: 275-284.
36. Renehan AG, Painter JE, Atkin WS, et al. (2001). High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 88: 107-113.
37. Rosen CJ (1999). Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications. Clin Chem 45: 1384-1390.
38. Savage MO, Camacho-Hübner C, Dunger DB, et al. (2001). Is there a medical need to explore the clinical use of insulin-like growth factor I? Growth Hormone IGF Res 11: S65-S69.
39. Sjögren K, Wallenius K, Liu JL, et al. (2001). Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50: 1539-1545.
40. Stoll BA (1999). Western nutrition and insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 53: 83-87.
41. Stoll BA (2000). Adiposity as a risk determinant for postmenopausal breast cancer. Int J Obes Relat Metabol Disord 24: 527-533.
42. Thrailkill KM (2000). Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther 2: 69-80.
43. Valle M, Gascón F, Martos R, et al. (2002). Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels. Metabolism 51: 423-428.
44. Yasunaga T, Furukawa S, Katsumata N, et al. (1998). Nutrition related hormonal changes in obese children. Endocrinol J 45: 221-227.